UNSPSC 51263153: Bisoprolol hydrochloride

This classification denotes a beta-adrenergic blocking agent with the molecular formula C18H31NO4.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2EX58570NP. Most nations, for tariff and trade purposes, schedule bisoprolol hydrochloride under HS 29221980. As of Q4 2014, BISOPROLOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC(C)NCC(COC1CCC(CC1)COCCOC(C)C)O.CL.

UNSPSC 51263153 Bisoprolol hydrochloride is a Commodity code that nominally describes a specific beta-blocker medication, but recent state and local opportunities tagged under this code show little alignment with the pharmaceutical product itself. The Seminole County, Florida IFB60459723LAS solicitation, posted June 30, 2026, and the Texas Health and Human Services Commission RFI HHS0017013, posted April 3, 2026, both focus on naloxone procurement and direct-to-manufacturer pharmacy contracting arrangements rather than bisoprolol or comparable cardiovascular drugs. The code appears to see limited or mislabeled recent activity in state and local procurement, with issuing bodies including a county health department and a state human services commission, but the work being solicited does not reflect the code's nominal pharmaceutical scope.

The geographic spread and representative opportunities show activity in Florida and Texas only within the recent window. Seminole County's IFB sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; response deadline was July 26, 2023. The Texas HHS Commission's RFI, with a response deadline of April 3, 2026, solicited vendor capabilities for a Therapeutic Pharmacy Initiative focused on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. Neither opportunity involves bisoprolol procurement, suggesting the code may be miscategorized in state and local systems or used as a default taxonomic placeholder rather than reflecting genuine buying patterns under this specific pharmaceutical line item.